[HTML] frontiersin.org

[HTML][HTML] Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer

Y Hu, SY Ren, RY Wang, C Zeng, JN Li, P Xiao… - Frontiers in …, 2021 - frontiersin.org
Background Neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer
(NSCLC) represents an important research topic. Despite the potential benefits of this …
被引用次数：12 相关文章

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

Y Hu, SY Ren, RY Wang, C Zeng, JN Li… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer
(NSCLC) represents an important research topic. Despite the potential benefits of this …

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer.

Y Hu, SY Ren, RY Wang, C Zeng, JN Li, P Xiao… - Frontiers in …, 2021 - europepmc.org
Background Neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer
(NSCLC) represents an important research topic. Despite the potential benefits of this …
[HTML] nih.gov

[HTML][HTML] Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

Y Hu, SY Ren, RY Wang, C Zeng, JN Li… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background Neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer
(NSCLC) represents an important research topic. Despite the potential benefits of this …

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer.

Y Hu, SY Ren, RY Wang, C Zeng, JN Li, P Xiao… - Frontiers in …, 2021 - europepmc.org
Background Neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer
(NSCLC) represents an important research topic. Despite the potential benefits of this …